Some of the upcoming changes to financing cancer treatments here are good and should cut down needless expenditure.
Higher subsidies, raising the income level so more people qualify for such subsidies and negotiating with drug companies to reduce their prices are all moves in the right direction.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
